Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Convalescent Plasma
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : RSPAD Gatot Soebroto | Fundo de Incentivo à Pesquisa do Hospital de Clínicas de Porto Alegre
Deal Size : Inapplicable
Deal Type : Inapplicable
Convalescent Plasma Therapy in Patients With COVID-19
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 29, 2020
Lead Product(s) : Convalescent Plasma
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : RSPAD Gatot Soebroto | Fundo de Incentivo à Pesquisa do Hospital de Clínicas de Porto Alegre
Deal Size : Inapplicable
Deal Type : Inapplicable